These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34285459)

  • 1. Securing circulation pharmaceutically: Antiviral stockpiling and pandemic preparedness in the European Union.
    Elbe S; Roemer-Mahler A; Long C
    Secur Dialogue; 2014 Oct; 45(5):440-457. PubMed ID: 34285459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical countermeasures for national security: a new government role in the pharmaceuticalization of society.
    Elbe S; Roemer-Mahler A; Long C
    Soc Sci Med; 2015 Apr; 131():263-71. PubMed ID: 24815579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Pandemic Influenza Preparedness: Antiviral strategy.
    Henry B
    Can Commun Dis Rep; 2019 Jan; 45(1):38-43. PubMed ID: 31015817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmaceuticalisation of security: Molecular biomedicine, antiviral stockpiles, and global health security.
    Elbe S
    Rev Int Stud; 2014 Dec; 40(5):919-938. PubMed ID: 27570356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.
    Reddy D
    J Antimicrob Chemother; 2010 Apr; 65 Suppl 2(Suppl 2):ii35-ii40. PubMed ID: 20215134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.
    Vilhelmsson A; Mulinari S
    J Public Health (Oxf); 2018 Sep; 40(3):646-651. PubMed ID: 28977398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.
    Meijer A; Lackenby A; Hay A; Zambon M
    Euro Surveill; 2007 Apr; 12(4):E3-4. PubMed ID: 17991386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stockpiling antiviral drugs for the next influenza pandemic.
    Patel A; Gorman SE
    Clin Pharmacol Ther; 2009 Sep; 86(3):241-3. PubMed ID: 19707215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare system cost evaluation of antiviral stockpiling for pandemic influenza preparedness.
    Li Y; Hsu EB; Links JM
    Biosecur Bioterror; 2010 Jun; 8(2):119-28. PubMed ID: 20569054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pandemics, antiviral stockpiles and biosecurity in Australia: what about the generic option?
    Lokuge B; Drahos P; Neville W
    Med J Aust; 2006 Jan; 184(1):16-20. PubMed ID: 16398625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
    Chawla R; Sharma RK; Bhardwaj JR
    Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage.
    Watson SI; Chen YF; Nguyen-Van-Tam JS; Myles PR; Venkatesan S; Zambon M; Uthman O; Chilton PJ; Lilford RJ
    F1000Res; 2016; 5():2293. PubMed ID: 28413608
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in and shortcomings of drug stockpiling, vaccine development and related policies during outbreaks of avian influenza A H5N1, H1N1, and H7N9 among humans.
    Mei L; Tang Q; Cui YM; Tobe RG; Selotlegeng L; Ali AH; Xu LZ
    Drug Discov Ther; 2013 Jun; 7(3):95-100. PubMed ID: 23917856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Tamiflu fiasco and lessons learnt.
    Gupta YK; Meenu M; Mohan P
    Indian J Pharmacol; 2015; 47(1):11-6. PubMed ID: 25821304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial response of health care institutions to emergence of H1N1 influenza: experiences, obstacles, and perceived future needs.
    Lautenbach E; Saint S; Henderson DK; Harris AD
    Clin Infect Dis; 2010 Feb; 50(4):523-7. PubMed ID: 20064038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.
    Arino J; Bowman CS; Moghadas SM
    BMC Infect Dis; 2009 Jan; 9():8. PubMed ID: 19161634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-prioritized use of antivirals during an influenza pandemic.
    Merler S; Ajelli M; Rizzo C
    BMC Infect Dis; 2009 Jul; 9():117. PubMed ID: 19638194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivirals in the 2009 pandemic--lessons and implications for future strategies.
    Berera D; Zambon M
    Influenza Other Respir Viruses; 2013 Nov; 7 Suppl 3(Suppl 3):72-9. PubMed ID: 24215385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of optimal antiviral stockpile for a novel influenza pandemic.
    Kim S; Bin Seo Y; Lee J; Kim YS; Jung E
    J Infect Public Health; 2022 Jul; 15(7):720-725. PubMed ID: 35667304
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.